Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 11

Results: 15

TIGIT: a novel immunotherapy target moving from bench to bedside.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1659, doi. 10.1007/s00262-018-2246-5

By:

Solomon, Benjamin L.;
Garrido-Laguna, Ignacio

Publication type:

Article

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1797, doi. 10.1007/s00262-018-2242-9

By:

Weber, Alexander N. R.;
Cardona Gloria, Yamel;
Çınar, Özcan;
Reinhardt, H. Christian;
Pezzutto, Antonio;
Wolz, Olaf-Oliver

Publication type:

Article

International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1809, doi. 10.1007/s00262-018-2240-y

By:

Berraondo, Pedro;
Aznar, Maria Angela;
Perez-Ruiz, Elisabeth;
Rodriguez-Ruiz, Maria Esperanza;
Castañon, Eduardo;
Perez-Gracia, Jose Luis;
Melero, Ignacio

Publication type:

Article

TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1719, doi. 10.1007/s00262-018-2237-6

By:

Jin, Ya-bin;
Luo, Wei;
Zhang, Guo-yi;
Lin, Kai-rong;
Cui, Jin-huan;
Chen, Xiang-ping;
Pan, Ying-ming;
Mao, Xiao-fan;
Tang, Jun;
Wang, Yue-jian

Publication type:

Article

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1731, doi. 10.1007/s00262-018-2234-9

By:

Alexander, Matthew P.;
Fiering, Steven N.;
Ostroff, Gary R.;
Cramer, Robert A.;
Mullins, David W.

Publication type:

Article

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1777, doi. 10.1007/s00262-018-2232-y

By:

Yao, Yu;
Luo, Feifei;
Tang, Chao;
Chen, Dikang;
Qin, Zhiyong;
Hua, Wei;
Xu, Ming;
Zhong, Ping;
Yu, Shuangquan;
Chen, Di;
Ding, Xiaojie;
Zhang, Yi;
Zheng, Xiujuan;
Yang, Jiao;
Qian, Jiawen;
Deng, Yuting;
Hoon, Dave S. B.;
Hu, Jian;
Chu, Yiwei;
Zhou, Liangfu

Publication type:

Article

PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1669, doi. 10.1007/s00262-018-2231-z

By:

Haeryfar, S. M. Mansour;
Schell, Todd D.

Publication type:

Article

IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1695, doi. 10.1007/s00262-018-2230-0

By:

Plaumann, Julian;
Engelhardt, Melanie;
Awwad, Mohamed H. S.;
Echchannaoui, Hakim;
Amman, Eva;
Raab, Marc S.;
Hillengass, Jens;
Halama, Niels;
Neuber, Brigitte;
Müller-Tidow, Carsten;
Goldschmidt, Hartmut;
Hundemer, Michael

Publication type:

Article

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1767, doi. 10.1007/s00262-018-2228-7

By:

Wieland, Andreas;
Kamphorst, Alice O.;
Adsay, N. Volkan;
Masor, Jonathan J.;
Sarmiento, Juan;
Nasti, Tahseen H.;
Darko, Sam;
Douek, Daniel C.;
Xue, Yue;
Curran, Walter J.;
Lawson, David H.;
Ahmed, Rafi

Publication type:

Article

Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1685, doi. 10.1007/s00262-018-2227-8

By:

Xie, Shan;
Huang, Jia;
Qiao, Qin;
Zang, Wenjuan;
Hong, Shanjuan;
Tan, Haidong;
Dong, Chen;
Yang, Zhiying;
Ni, Ling

Publication type:

Article

Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1673, doi. 10.1007/s00262-018-2225-x

By:

Kato, Ryo;
Yamasaki, Makoto;
Urakawa, Shinya;
Nishida, Kentaro;
Makino, Tomoki;
Morimoto-Okazawa, Akiko;
Kawashima, Atsunari;
Iwahori, Kota;
Suzuki, Susumu;
Ueda, Ryuzo;
Mori, Masaki;
Satoh, Taroh;
Doki, Yuichiro;
Wada, Hisashi

Publication type:

Article

Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1709, doi. 10.1007/s00262-018-2224-y

By:

Neumann, Frank;
Acker, Fabian;
Schormann, Claudia;
Pfreundschuh, Michael;
Bittenbring, Joerg Thomas

Publication type:

Article

Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1743, doi. 10.1007/s00262-018-2213-1

By:

Lin, Kai-Rong;
Pang, Dan-Mei;
Jin, Ya-Bin;
Hu, Qian;
Pan, Ying-Ming;
Cui, Jin-Huan;
Chen, Xiang-Ping;
Lin, Yin-Xin;
Mao, Xiao-Fan;
Duan, Hai-Bo;
Luo, Wei

Publication type:

Article

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1789, doi. 10.1007/s00262-018-2205-1

By:

Raaijmakers, Tonke K.;
Ansems, Marleen

Publication type:

Article

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1753, doi. 10.1007/s00262-018-2199-8

By:

Wahba, John;
Natoli, Marina;
Whilding, Lynsey M.;
Parente-Pereira, Ana C.;
Jung, Youngrock;
Zona, Stefania;
Lam, Eric W.-F.;
Smith, J. Richard;
Maher, John;
Ghaem-Maghami, Sadaf

Publication type:

Article

Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 11

TIGIT: a novel immunotherapy target moving from bench to bedside.

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.

International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.

TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung.

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.

PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois.

IL-10 inducible CD8<sup>+</sup> regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.

Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.

Increased Tim-3<sup>+</sup> T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.

Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.

Circulating CD8<sup>+</sup> T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands.

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.